Literature DB >> 17400757

Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.

Munetaka Matoba1, Hisao Tonami, Tamaki Kondou, Hajime Yokota, Kotaro Higashi, Hirohisa Toga, Tutomu Sakuma.   

Abstract

PURPOSE: To prospectively evaluate diffusion-weighted (DW) magnetic resonance (MR) imaging with a split acquisition of fast spin-echo signals for diffusion imaging (SPLICE) sequence for tissue characterization of lung carcinomas by using apparent diffusion coefficients (ADCs).
MATERIALS AND METHODS: An institutional review board approved this study; informed consent was obtained from patients. Thirty patients (nine women, 21 men; mean age, 68.0 years) with lung carcinoma underwent DW MR imaging with the SPLICE sequence. ADC of each lung carcinoma was calculated from DW MR images obtained with low and high b values. ADCs of lung carcinomas were statistically compared among histologic types. Nine surgically excised lung carcinomas were evaluated for correlation between ADCs and tumor cellularities. Analysis of variance was used to determine changes in ADCs and histologic lung carcinoma types. Spearman rank correlation was calculated between ADCs and tumor cellularities.
RESULTS: ADCs for lung carcinomas were 1.63 x 10(-3) mm(2)/sec +/- 0.5 (mean +/- standard deviation) for squamous cell carcinoma, 2.12 x 10(-3) mm(2)/sec +/- 0.6 for adenocarcinoma, 1.30 x 10(-3) mm(2)/sec +/- 0.4 for large-cell carcinoma, and 2.09 x 10(-3) mm(2)/sec +/- 0.3 for small-cell carcinoma. ADC of adenocarcinoma was significantly higher than that of squamous cell carcinoma and large-cell carcinoma (P < .05). ADCs were 1.59 x 10(-3) mm(2)/sec +/- 0.5 and 1.70 x 10(-3) mm(2)/sec +/- 0.4 for moderately and poorly differentiated squamous cell carcinoma, respectively. ADCs were 2.52 x 10(-3) mm(2)/sec +/- 0.4 and 1.44 x 10(-3) mm(2)/sec +/- 0.3 for well- and poorly differentiated adenocarcinoma, respectively. ADC of well-differentiated adenocarcinoma was significantly higher than that of moderately and poorly differentiated squamous cell carcinoma and poorly differentiated adenocarcinoma (P < .05). With the Spearman rank test, ADCs of lung carcinomas correlated well with tumor cellularities (Spearman coefficient, -0.75; P < .02).
CONCLUSION: ADCs of lung carcinomas overlap, but ADCs of well-differentiated adenocarcinoma appear to be higher than those of other histologic lung carcinoma types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400757     DOI: 10.1148/radiol.2432060131

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  62 in total

1.  Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.

Authors:  Gregor Sommer; Mark Wiese; Leopold Winter; Claudia Lenz; Markus Klarhöfer; Flavio Forrer; Didier Lardinois; Jens Bremerich
Journal:  Eur Radiol       Date:  2012-07-09       Impact factor: 5.315

2.  Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging.

Authors:  Johan Coolen; Johan Vansteenkiste; Frederik De Keyzer; Herbert Decaluwé; Walter De Wever; Christophe Deroose; Christophe Dooms; Eric Verbeken; Paul De Leyn; Vincent Vandecaveye; Dirk Van Raemdonck; Kristiaan Nackaerts; Steven Dymarkowski; Johny Verschakelen
Journal:  Eur Radiol       Date:  2013-10-31       Impact factor: 5.315

3.  Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT.

Authors:  Kyung Eun Shin; Chin A Yi; Tae Sung Kim; Ho Yun Lee; Young Soo Choi; Hong Kwan Kim; Jhingook Kim
Journal:  Eur Radiol       Date:  2013-11-01       Impact factor: 5.315

4.  Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas.

Authors:  Hisanobu Koyama; Yoshiharu Ohno; Nobukazu Aoyama; Yumiko Onishi; Keiko Matsumoto; Munenobu Nogami; Daisuke Takenaka; Wataru Nishio; Chiho Ohbayashi; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2009-09-18       Impact factor: 5.315

5.  [(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.

Authors:  Alexis Vrachimis; Lars Stegger; Christian Wenning; Benjamin Noto; Matthias Christian Burg; Julia Renate Konnert; Thomas Allkemper; Walter Heindel; Burkhard Riemann; Michael Schäfers; Matthias Weckesser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-08       Impact factor: 9.236

6.  Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis.

Authors:  Guohua Shen; Zhiyun Jia; Houfu Deng
Journal:  Eur Radiol       Date:  2015-05-24       Impact factor: 5.315

7.  Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging.

Authors:  Sevtap Gümüştaş; Nagihan Inan; Hasan Tahsin Sarisoy; Yonca Anik; Arzu Arslan; Ercüment Ciftçi; Gür Akansel; Ali Demirci
Journal:  Eur Radiol       Date:  2011-06-23       Impact factor: 5.315

8.  Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum.

Authors:  F Tondo; A Saponaro; A Stecco; M Lombardi; C Casadio; A Carriero
Journal:  Radiol Med       Date:  2011-02-01       Impact factor: 3.469

9.  Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size.

Authors:  Hiroaki Nomori; Yue Cong; Hiroshi Sugimura; Yoshiaki Kato
Journal:  Surg Today       Date:  2015-02-13       Impact factor: 2.549

Review 10.  Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review.

Authors:  Bruno Hochhegger; Matheus Zanon; Stephan Altmayer; Gabriel S Pacini; Fernanda Balbinot; Martina Z Francisco; Ruhana Dalla Costa; Guilherme Watte; Marcel Koenigkam Santos; Marcelo C Barros; Diana Penha; Klaus Irion; Edson Marchiori
Journal:  Lung       Date:  2018-10-09       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.